Key Events This Week
24 Aug: Stock surged 6.20% to ₹1,468.60
26 Aug: New 52-week high at ₹1,579.20; Mojo rating upgraded to Sell
27 Aug: Fresh 52-week high at ₹1,593.95 despite slight daily pullback
28 Aug: Week closes at ₹1,538.65, up 1.51% on the day

Bharat Parenterals Ltd Hits New 52-Week High of Rs 1593.95 on Back of Strong Technical Signals
2026-08-27 09:51:05From a 52-week low of Rs 880.25 to a fresh peak of Rs 1593.95, Bharat Parenterals Ltd has delivered an 81% rally over the past year, outpacing the Sensex which declined by 4.07% in the same period. This milestone was reached on 27 Aug 2026, driven predominantly by a confluence of bullish technical indicators and sustained price momentum.
Read full news article
Bharat Parenterals Ltd Hits New 52-Week High of Rs 1579.2 on Back of Strong Technical Signals
2026-08-26 11:41:33A sustained rally has propelled Bharat Parenterals Ltd to a fresh 52-week high of Rs 1579.2 on 26 Aug 2026, marking a notable 24.85% gain over the past five trading sessions and outpacing its sector by 6.02% today alone.
Read full news article
Bharat Parenterals Ltd Upgraded to Sell Amid Mixed Financial and Technical Signals
2026-08-26 08:27:07Bharat Parenterals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 25 Aug 2026, reflecting a nuanced shift in its technical outlook despite ongoing financial challenges. The upgrade is primarily driven by improved technical indicators, while valuation and financial trends continue to weigh on investor sentiment. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the recent rating change.
Read full news article
Bharat Parenterals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades
2026-08-26 08:04:52Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by improvements in key technical indicators such as the MACD, Bollinger Bands, and moving averages, signalling potential opportunities for investors despite the company’s current Sell rating and modest Mojo Score of 31.0.
Read full news article
Bharat Parenterals Ltd is Rated Strong Sell
2026-08-21 10:10:59Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 07 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article







